Financings Of The Fortnight: Biotech Investments' Internal Rate Of Return Trails Other Sectors Badly
This article was originally published in The Pink Sheet Daily
Executive Summary
Plus news on recent financings by Horizon Pharma, Argos Therapeutics, BrainCells and Baxter Ventures.